IGM Biosciences, Inc. Deferred Income, Current
IGM Biosciences, Inc. had Deferred Income, Current of $0 as of 2025-06-30, per its 10-Q filed 2025-07-31.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredIncomeCurrent · last filed 2025-07-31
- 2025-06-30: Deferred Income, Current $0.00.
- 2025-03-31: Deferred Income, Current $2.75M.
- 2024-12-31: Deferred Income, Current $2.65M.
- 2024-09-30: Deferred Income, Current $2.65M.
| Period end | Deferred Income, Current |
|---|---|
| 2025-06-30 | $0.00 10-Q · filed 2025-07-31 |
| 2025-03-31 | $2.75M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $2.65M 10-Q · filed 2025-07-31 |
| 2024-09-30 | $2.65M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $2.00M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $3.65M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $3.78M 10-K · filed 2025-03-06 |
| 2023-09-30 | $4.91M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $4.75M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $3.60M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $2.74M 10-K · filed 2024-03-07 |
| 2022-09-30 | $4.76M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $3.52M 10-Q · filed 2022-08-08 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-30 |